维普中文期刊产品整合服务
20篇 您的检索式:作者名="MAJEM M"
    题名 作者 年代 出处 被引量
1诱导化疗后分割放疗治疗无法手术切除的头颈部鳞癌患者显示文摘该文旨在评价诱导化疗后再行分割放疗对无法切除的头颈部鳞癌患者的疗效。对1994~2000年间99例无法手术的头颈癌患者进行回顾性研究,67例T4,88例N2-N3。肿瘤部位:62例口咽部,22例下咽部,8例口腔,7例喉。Mesia R Majem M Barretina Ginesta 2008中国口腔颌面外科杂志2008,6,1:2
2An update on molecularly targe- ted therapies in second- and third-line treatment in non- small cell lung cancer: focus on EGFR inhibitors and anti-angiogenic agents 显示文摘Majem M Pallars C 2013Clin Transl Oncol2013,15,5:1
3Molecular bases of endometrial cancer:new roles for new actors in the diagnosis and the therapy of the disease显示文摘Llauradó M Ruiz A Majem B 0,,02:1
4MicroRNAs as prognostic marker in ovarian cancer显示文摘Llauradó M Majem B Altadill T 2014Mol Cell Endocrinol2014,390,12:1
5Tumor heterogeneity:evolution through space and time in EGFR mutant non small cell lung cancer patients显示文摘Majem M Remon J 2013Transl Lung Cancer Res2013,2,3:1
6Tumor heterogeneity:evolution through space and time in EGFR mutant non small cell lung cancer patients显示文摘Majem M Remon J 2013Transl Lung Cancer Res2013,2,3:1
7Phammcogenetics of the DNA repair pathways in advanced non - small cell lung cancer patients treated with platinum- based chemotherapy 显示文摘Sullivan 1 Salazar J Majem M 2014Cancer Lett2014,353,:1
8Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy显示文摘Sullivan I Salazar J Majem M 2014Cancer letters2014,353,2:1
9Lung cancer in women:an overview with special focus on Spanish wom- en显示文摘Remon J Molina-Montes E Majem M 2014Clin Transl Oncol2014,16,6:1
10Control of E1A under an E2F-1 promoter insulated with the myotonie dystrophy locus insulator reduces the toxicity of oneolytic adenovirus Ad-R24RGD 显示文摘Majem M Cascallo M Bayo-Puxan IN etal 2006Cancer Gene Ther2006,13,7:1
11The predictive value of BRCAland RAP80 mRNA expression in advanced non-small-cell lung cancerpatients treated with platinum-based chemotherapy显示文摘Bonanno L Costa C Majem M 2013Annals of onc-ology:official journal of the European Society for Medical Oncology/ESMO''2013,24,4:1
12Tumor heterogeneity: evolution through spaceand time in EGFR mutant non-small cell lung cancer patients显示文摘Majem M Remon J 2013Transl Lung Cancer Res2013,2,3:1
13Acquired resistance toepidermal growth factor receptor tyrosine kinase inhibitors in EG-FR-mutant non-small cell lung cancer: A new era begin显示文摘REMON J MORAN T MAJEM M 2014Cancer Treat Rev2014,40,1:1
14Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in EGFR-mutant nonsmall cell lung cancer:A new era begins显示文摘Remon J Moran T Majem M 2014Cancer Treat Rev2014,40,1:1
15Tumor heterogeneity: evolution through space and time in EGFR mutant non small cell lung cancer patients显示文摘Majem M Remon J 2013Transl Lung Cancer Res2013,2,3:1
16Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in EGFR - mutant non -small cell lung cancer: a new era begins显示文摘REMON J MORAN T MAJEM M 2014Cancer Treat Rev2014,40,1:1
17Acquired resistance toepidermal growth factor receptor tyrosine kinase inhibitors in EG-FR-mutant non-small cell lung cancer: A new era begins 显示文摘REMON J MORAN T MAJEM M 2013Cancer Treat Rev’2013,,13:1
18Tumor heterogeneity: evolution through space and time in EGFR mutant non small cell lung cancer patients 显示文摘MAJEM M REMON J 2013Transl Lung Cancer Res2013,2,3:1
19Acquired resistance to epidermal growth factor receptor tyro- sine kinase inhibitors in EGFR-mutant non-small cell lung cancer: a new era begins 显示文摘REMON J MORAN T MAJEM M 2014Cancer Treat Rev2014,40,1:1
20An update on molecularly targeted therapies in second-and third-line treatment in non-small cell lung cancer:focus on EGFR inhibitors and anti-angiogenic agents 显示文摘Majem M Pallars C 2013Clin Transl Oncol2013,15,5:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费